Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Temozolomide for cerebral metastases after radiation failure
NCT00012116Phase 2Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- Oct 2000
- Primary completion
- Apr 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in brain metastases, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started Oct 2000; status: completed.
02
Drugs
temozolomide
03
Conditions
brain metastases
Beyond the preview
Go deeper on NCT00012116.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00012116.